For over 40 years, my observation has been that low levels of essential amino acids are one major cause of depression. Among very many other things, our bodies use amino acids to make the large majority of “neurotransmitters,” molecules which help nerve cells to communicate. If essential amino acids are low, then neurotransmitters are very likely to be low also, and depression is a frequent result. Patent medicine companies know this too; but since amino acids aren’t patentable, they’ve looked for artificial, patentable molecules to raise levels of neurotransmitters. Many patent “antidepressants” do exactly that.
Mrs. Jones (of course not her real name) came to see me at Tahoma Clinic sometime in the 1990s with several problems. The main one was chronic depression; it was “successfully” being treated with one of the common patented antidepressants that raise neurotransmitter levels. As is more usual than not, the patented antidepressant was also causing “side effects.”









0 Comments